ecrin-mdr-crcClinical2014Metastatic Colorectal CancerColorectal carcinomaColorectal cancerColorectal NeoplasmsColorectal CarcinomaMetastatic Colorectal CancerColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2161964AustriaBelgiumItalyUnited KingdomFranceGermanyEstoniaSpain9MCRCCRCImmunotherapyMaintenance treatmentMGN1703MetastaticImmune modulationECRIN MDRNot providedfalseEvaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentThe purpose of this this trial is to prove the efficacy and safety of MGN1703 as a maintenance therapy after first-line chemotherapeutic treatment of metastatic colorectal cancer.2014-09-152161964NCT020778682014-000834-50